ETF Managers Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,621	Closed	-$424K	–	661
2021 Q1	$424K	Buy	7,621 +1,361	+22%	+$103K	0.01%	517
2020 Q4	$435K	Buy	6,260 +2,486	+66%	+$339K	0.01%	404
2020 Q3	$917K	Buy	3,774 +293	+8%	+$60K	0.03%	218
2020 Q2	$579K	Sell	3,481 -932	-21%	-$100K	0.02%	247
2020 Q1	$299K	Buy	4,413 +392	+10%	+$30.6K	0.01%	308
2019 Q4	$259K	Sell	4,021 -555	-12%	-$32.2K	0.01%	462
2019 Q3	$266K	Buy	4,576 +1,746	+62%	+$103K	0.01%	316
2019 Q2	$169K	Sell	2,830 -1,484	-34%	-$86.4K	0.01%	493
2019 Q1	$281K	Sell	4,314 -139	-3%	-$7.91K	0.01%	267
2018 Q4	$237K	Buy	4,453 +1,920	+76%	+$94.6K	0.01%	281
2018 Q3	$145K	Buy	2,533 +596	+31%	+$36K	0.01%	291
2018 Q2	$102	Sell	1,937 -67	-3%	-$3.94K	0.01%	226
2018 Q1	$96K	Buy	2,004 +334	+20%	+$16.8K	0.01%	292
2017 Q4	$91K	Buy	1,670 +384	+30%	+$23K	0.01%	248
2017 Q3	$79K	Buy	1,286 +79	+7%	+$5.11K	0.01%	149
2017 Q2	$75K	Buy	+1,207	New	+$74.4K	0.01%	207